Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to confirm the safety profile for long term treatment and maximize doses and the control status on bronchial asthma in daily clinical usage
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of Adverse Events | Range of one year |
| Measure | Description | Time Frame |
|---|---|---|
| The level of asthma control under long-term use | At the end of 24 weeks | |
| The level of asthma control under long-term use | At the end of one year |
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
Patients treated with Symbicort for the first time due to bronchial asthma
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yoshida Shigeru | AstraZeneca | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Aichi | Japan | Japan | |||
| Research Site |
Not provided
Not provided
Not provided
Not provided
| Akita |
| Japan |
| Japan |
| Research Site | Aomori | Japan | Japan |
| Research Site | Chiba | Japan | Japan |
| Research Site | Ehime | Japan | Japan |
| Research Site | Fukui | Japan | Japan |
| Research Site | Fukuoka | Japan | Japan |
| Research Site | Fukushima | Japan | Japan |
| Research Site | Gifu | Japan | Japan |
| Research Site | Gunma | Japan | Japan |
| Research Site | Hiroshima | Japan | Japan |
| Research Site | Hokkaido | Japan | Japan |
| Research Site | Hyōgo | Japan | Japan |
| Research Site | Ibaraki | Japan | Japan |
| Research Site | Ishikawa | Japan | Japan |
| Research Site | Kagawa | Japan | Japan |
| Research Site | Kagoshima | Japan | Japan |
| Research Site | Kanagawa | Japan | Japan |
| Research Site | Kochi | Japan | Japan |
| Research Site | Kumamoto | Japan | Japan |
| Research Site | Kyoto | Japan | Japan |
| Research Site | Mie | Japan | Japan |
| Research Site | Miyagi | Japan | Japan |
| Research Site | Miyazaki | Japan | Japan |
| Research Site | Nagano | Japan | Japan |
| Research Site | Nagasaki | Japan | Japan |
| Research Site | Nara | Japan | Japan |
| Research Site | Niigata | Japan | Japan |
| Research Site | Numakunai | Japan | Japan |
| Research Site | Okayama | Japan | Japan |
| Research Site | Okinawa | Japan | Japan |
| Research Site | Osaka | Japan | Japan |
| Research Site | Ōita | Japan | Japan |
| Research Site | Saga | Japan | Japan |
| Research Site | Saitama | Japan | Japan |
| Research Site | Shiga | Japan | Japan |
| Research Site | Shimane | Japan | Japan |
| Research Site | Shizuoka | Japan | Japan |
| Research Site | Tochigi | Japan | Japan |
| Research Site | Tokushima | Japan | Japan |
| Research Site | Tokyo | Japan | Japan |
| Research Site | Tottori | Japan | Japan |
| Research Site | Toyama | Japan | Japan |
| Research Site | Wakayama | Japan | Japan |
| Research Site | Yamagata | Japan | Japan |
| Research Site | Yamaguchi | Japan | Japan |
| Research Site | Yamanashi | Japan | Japan |
| ID | Term |
|---|---|
| D001249 | Asthma |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012130 | Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |
Not provided
Not provided